Conavi Medical Corp. (CNVIF)

Market Cap	17.91M
Revenue (ttm)	1.60M
Net Income (ttm)	-32.28M
Shares Out	n/a
EPS (ttm)	-5.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,427
Average Volume	3,386
Open	0.457
Previous Close	0.440
Day's Range	0.430 - 0.493
52-Week Range	0.001 - 1.000
Beta	n/a
RSI	47.79
Earnings Date	Mar 7, 2025

About Conavi Medical

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Thomas Looby
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNVIF

Financial Performance

In 2024, Conavi Medical's revenue was 2.16 million, a decrease of -8.59% compared to the previous year's 2.36 million. Losses were -43.62 million, 67.2% more than in 2023.

Financial numbers in CAD